Rc. Williams et al., AFFINITY COLUMNS CONTAINING ANTI-DNA ID-GLOBULIN( HUMAN MYELOMA PROTEINS ADSORB HUMAN EPIBODIES FROM INTRAVENOUS GAMMA), Arthritis and rheumatism, 40(4), 1997, pp. 683-693
Objective. To study eluates of intravenous gamma globulin (IVGG) prepa
red from affinity columns of human cationic IgG myeloma proteins beari
ng anti-DNA idiotype (Id) markers 16/6, F4, 3I, and 8.12 for possible
anti-Id (combining site) blocking activity. Methods. Anti-DNA idiotypi
c antibody activity was studied in 3 preparations of IVGG containing h
igh, medium, and low levels of IgG anti-F(ab')(2), and in 4 other comm
ercial IVGG preparations, Affinity-purified IgG anti-DNA (APAD) from s
ystemic lupus erythematosus (SLE) patients was biotinylated, and bindi
ng to DNA coated on enzyme-linked immunosorbent assay plates was used
to measure anti-DNA antibody activity, IVGG was adsorbed to Sepharose
4B affinity columns linked to a panel of cationic human IgG myeloma pr
oteins positive for anti-DNA Id markers 16/6, F4, 3I, and 8.12, Materi
al adsorbing to such columns was eluted at low pH (2.5) and after neut
ralization, tested for its ability to inhibit biotinylated APAD reacti
ng with DNA. Results. Only 0.05-0.9% of IVGGs bound firmly to Id affin
ity columns, These IVGGs were then eluted, using pH 2.5 glycine-saline
and eluates neutralized to pH 7.4, Column flowthrough and eluate frac
tions were compared for their ability to block SLE APAD reacting with
DNA, Significant inhibition of SLE APAD combining sites was observed w
ith eluates from anti-DNA Id affinity columns; however, no correlation
between IVGG anti-F(ab')(2) activity and true anti-Id blocking of APA
D was apparent, No residual anti-id activity remained in column flowth
rough fractions, No anti-Id blocking activity was recorded for IVGG el
uates from human cationic myeloma columns devoid of the 4 anti-DNA Id
markers, DNase treatment of IVGG or Id column eluates did not affect a
nti-Id blocking activity, Thus, all detectable anti-DNA idiotypic anti
body capable of blocking SLE anti-DNA combining sites bound to Id+ aff
inity columns, Column eluates also showed some relative concentration
of IgG anti-DNA activity, which was of lower affinity for DNA than ant
ibodies also present in eluates which blocked anti-DNA combining sites
. Conclusion. The presence of both anti-DNA and antiidiotypic (anti-co
mbining site) activity in human anti-DNA Id column eluates indicates t
hat epibodies from IVGG are relatively concentrated when this strategy
is used, This approach may lead to a new strategy for treatment of SL
E nephritis.